A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays

This publication has 43 references indexed in Scilit:

• AIDS Vaccines Show Promise After Years of Frustration
  Science, 2001
• Rapid Definition of Five Novel HLA-A∗3002-Restricted Human Immunodeficiency Virus-Specific Cytotoxic T-Lymphocyte Epitopes by Elispot and Intracellular Cytokine Staining Assays
  Journal of Virology, 2001
• Efficacy Testing of Recombinant Human Immunodeficiency Virus (HIV) gp160 as a Therapeutic Vaccine in Early‐Stage HIV‐1–Infected Volunteers
  The Journal of Infectious Diseases, 2000
• HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
  Annual Review of Immunology, 1997
• HLA-A, -B, -DRB1, -DQA1, and -DQB1 polymorphism in thais
  Human Immunology, 1997
• HIV Type 1 Vaccine-Induced Cytotoxic T Cell Responses in Phase I Clinical Trials: Detection, Characterization, and Quantitation
  AIDS Research and Human Retroviruses, 1997
• HLA Class I nucleotide sequences, 1995
  Tissue Antigens, 1995
• Conservation of T cell receptor usage by HLA B27‐restricted influenza‐specific cytotoxic T lymphocytes suggests a general pattern for antigen‐specific major histocompatibility complex class I‐restricted responses
  European Journal of Immunology, 1993
• HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 ⁺ Population
  Science, 1993
• CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1
  Proceedings Of The Royal Society B-Biological Sciences, 1991